Amrize (AMRZ) EBITDA (2024 - 2026)

Amrize has disclosed EBITDA across 3 years of filings, most recently posting -$76.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$76.0 million, down 375.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 12.88% YoY), and the FY2025 annual result was $1.9 billion, down 13.17% from the prior year.
• EBITDA came in at -$76.0 million for Q1 2026 at Amrize, down from $475.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $844.0 million in Q3 2024 to a low of -$76.0 million in Q1 2026.
• The 3-year median for EBITDA is $603.0 million (2024), against an average of $495.6 million.
• Across the five-year window, EBITDA slipped 7.82% in 2025 and slumped 375.0% in 2026, its largest moves.
• Amrize's EBITDA stood at $537.0 million in 2024, then declined by 11.55% to $475.0 million in 2025, then slumped by 116.0% to -$76.0 million in 2026.
• The last three EBITDA figures came in at -$76.0 million (Q1 2026), $475.0 million (Q4 2025), and $778.0 million (Q3 2025), per Business Quant data.